Literature DB >> 22228047

Surgical management of insulinomas in multiple endocrine neoplasia type 1.

Francesco Giudici1, Gabriella Nesi, Maria Luisa Brandi, Francesco Tonelli.   

Abstract

OBJECTIVE: This study aimed to evaluate the accuracy of preoperative and intraoperative diagnostic tools and the surgical strategy to obtain cure in multiple endocrine neoplasia type 1 (MEN-1) patients affected with insulinoma.
METHODS: Eight MEN-1 patients (1992-2009) were operated on for hypoglycemic crisis. Preoperative tumor localization was carried out. Ultrasound and modification of the insulin/glucose (I/G) ratio were applied intraoperatively. Pancreatic lesions larger than 0.5 cm were removed by resection of the most affected pancreatic region and by enucleation of nodules in least affected regions.
RESULTS: Two pancreatoduodenectomies and 6 distal pancreatectomies were performed; enucleation of nodules was necessary in 6 patients. There was no postoperative mortality. At the histopathologic analysis, a mean of 6 macrotumors and of 15.5 microlesions were found. Intraoperative ultrasound proved a sensitivity of 87.5% for detecting pancreatic insulinoma. Decrease in the I/G ratio after resection predicted postoperative outcome in all patients. At a mean follow-up of 81.5 months, all patients were normoglycemic with no evidence of disease recurrence.
CONCLUSIONS: Multiple endocrine neoplasia type 1 insulinomas should be considered surgically curable. Pancreatic resection seems preferable to a less radical surgical approach in ensuring higher cure rates. Intraoperative ultrasound and I/G ratio are of value in the assessment of surgical decision and in the evaluation of the surgical cure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228047     DOI: 10.1097/MPA.0b013e3182374e08

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

Review 1.  Zollinger-Ellison syndrome: classical considerations and current controversies.

Authors:  Irene Epelboym; Haggi Mazeh
Journal:  Oncologist       Date:  2013-12-06

2.  Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary?

Authors:  Jerena Manoharan; Friedhelm Raue; Caroline L Lopez; Max B Albers; Carmen Bollmann; Volker Fendrich; Emily P Slater; Detlef K Bartsch
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

Review 3.  The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Authors:  M V Davi; A Pia; V Guarnotta; G Pizza; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2016-09-13       Impact factor: 4.256

4.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Authors:  M Falconi; B Eriksson; G Kaltsas; D K Bartsch; J Capdevila; M Caplin; B Kos-Kudla; D Kwekkeboom; G Rindi; G Klöppel; N Reed; R Kianmanesh; R T Jensen
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

Review 5.  Multiple Endocrine Neoplasia: Genetics and Clinical Management.

Authors:  Jeffrey A Norton; Geoffrey Krampitz; Robert T Jensen
Journal:  Surg Oncol Clin N Am       Date:  2015-07-27       Impact factor: 3.495

6.  Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.

Authors:  Francesco Tonelli; Francesco Giudici; Francesca Giusti; Maria Luisa Brandi
Journal:  Cancers (Basel)       Date:  2012-05-07       Impact factor: 6.639

7.  Small amounts of tissue preserve pancreatic function: Long-term follow-up study of middle-segment preserving pancreatectomy.

Authors:  Zipeng Lu; Jie Yin; Jishu Wei; Cuncai Dai; Junli Wu; Wentao Gao; Qing Xu; Hao Dai; Qiang Li; Feng Guo; Jianmin Chen; Chunhua Xi; Pengfei Wu; Kai Zhang; Kuirong Jiang; Yi Miao
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

8.  Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort.

Authors:  D J van Beek; S Nell; H M Verkooijen; I H M Borel Rinkes; G D Valk; M R Vriens
Journal:  Br J Surg       Date:  2020-04-30       Impact factor: 6.939

Review 9.  What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review.

Authors:  Samuel Frey; Eric Mirallié; Maëlle Le Bras; Nicolas Regenet
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

10.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.